This is the story of a remarkable philanthropic funding partnership, which, through a combination of inspiration, vision, expertise and action, plus an $8 million funding injection, championed a revolutionary method for treating those at risk from a pernicious group of diseases.

Tuesday, September 6, 2016
Max Houghton

On the rare occasion that an idea changes the course of history, it can offer a moment to pause and look back to its genesis; following the story upstream, from the rolling river of its success to the headwaters of its source.

This is the story of a remarkable philanthropic funding partnership, which, through a combination of inspiration, vision, expertise and action, plus an $8 million funding injection, championed a revolutionary method for treating those at risk from a pernicious group of diseases.

Click here to read United Voices: The Story of the END Fund.

 

 

 


Keep Reading

  1. News Article

    Principles Before Profit: Q&A With Legatum Group CEO Mark Stoleson

    LEARN MORE

  2. News Article

    How to keep the world’s most neglected people healthy

    LEARN MORE

  3. News Article

    Appointment of Ellen Agler as CEO of The END Fund

    LEARN MORE

^
TOP